Gianni Sava

In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes

C. Scolaro, Alberta Bergamo, L. Brescacin et al. · Journal of Medicinal Chemistry · 2005 · 769 citations · Full text

Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs

Alberta Bergamo, Gianni Sava · Dalton Transactions · 2011 · 430 citations

Pharmaceutical Science, Chemoprevention Strategy, Ruthenium Anticancer Compounds +20

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Suzanne Leijen, Sjaak A. Burgers, Paul Baas et al. · Investigational New Drugs · 2014 · 365 citations · Full text

Oncology, Phase I/ii Study, Medicine +10

Organometallic ruthenium-based antitumor compounds with novel modes of action

Wee Han Ang, Angela Casini, Gianni Sava et al. · Journal of Organometallic Chemistry · 2010 · 359 citations · Full text

Medicinal Chemistry, Novel Modes, Natural Sciences +4

Cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X = Cl, Br): synthesis, structure, and antitumor activity

Enzo Alessio, G. Mestroni, G. Nardin et al. · Inorganic Chemistry · 1988 · 326 citations

Inorganic Chemistry, Medicinal Chemistry, Dimethyl Sulfoxide +12